Assessing target lesion score via daily photograph capture in subjects with psoriasis vulgaris on the body treated once daily with topical LEO 90100 (calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g [as dipropionate]) or vehicle.
Latest Information Update: 23 Feb 2023
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms PSO-IDEAL
- Sponsors LEO Pharma
Most Recent Events
- 23 Feb 2023 This trial has been completed in Denmark (End Date: 02 Feb 2023), according to European Clinical Trials Database record.
- 10 Mar 2022 Planned number of patients changed from 210 to 105.
- 30 Nov 2021 New trial record